Washington Research Foundation has given over $190 million in grants to Washington state nonprofit research institutions since 1993. Details since 2016 are shown below.
If you believe your research is a good match for one of our programs, we welcome the opportunity to discuss it with you. Please contact Meher Antia, Ph.D., at grants@wrfseattle.org or (206) 336-5600 for more information.
| Year | Institution | Department | Type of Grant | Amount |
|---|---|---|---|---|
| Year: 2025 | Institution: Benaroya Research Institute | Department: |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship |
Amount: $109,413 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Translational Science and Therapeutics |
Type of Grant:
Technology Commercialization
Miller: Developing CAR T-cell therapy targeting FOLR1 in renal cell carcinoma phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Translational Science and Therapeutics |
Type of Grant:
Technology Commercialization
Radtke: Portable in vivo gene therapy with multiplexed virus-like particles (MVPs) phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Vaccine & Infectious Disease Division |
Type of Grant:
Technology Commercialization
Walter: CRISPR-based gene drive treatment against herpes simplex virus 2 phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: |
Type of Grant:
Technology Commercialization
Technology commercialization grants: multiple projects |
Amount: $1,000,000 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Clinical Research Division |
Type of Grant:
IND-Enabling
Chapuis: Next generation TCR-T therapy for Merkel cell carcinoma |
Amount: $937,500 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Basic Sciences |
Type of Grant:
Technology Commercialization
Singhvi: Role of glia in neurodegeneration phase 1 indirect costs award |
Amount: $9,400 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Basic Sciences |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowships |
Amount: $466,851 |
| Year: 2025 | Institution: Fred Hutchinson Cancer Center | Department: Human Biology |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowships |
Amount: $297,295 |
| Year: 2025 | Institution: Nucleate | Department: |
Type of Grant:
Sponsorships & Other
Activator program |
Amount: $5,000 |
| Year: 2025 | Institution: Pacific Northwest National Laboratory | Department: |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship |
Amount: $47,500 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: Childhood Cancer Research |
Type of Grant:
Technology Commercialization
Crook: Developing a CNS-pentrant treatment for neuroinflammation phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: |
Type of Grant:
Planning
WRF Postdoctoral Fellowship |
Amount: $106,940 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: |
Type of Grant:
Postdoctoral Programs
Olson: Invent at Seattle Children’s Postdoctoral Scholars Program |
Amount: $3,180,000 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: Childhood Cancer Research |
Type of Grant:
Technology Commercialization
Jamet: Development of multi-specific T-cell engaging antibodies to target mixed-phenotype acute leukemia phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: Childhood Cancer Research |
Type of Grant:
Technology Commercialization
Carney: Preclinical design of a selective small molecule inhibitor against YBX1 phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: Center for Global Infectious Disease Research |
Type of Grant:
Technology Commercialization
van Zyl: N-myristoyltransferase inhibitors for the treatment and elimination of dormant forms of Plasmodium vivax malaria phase 1 indirect costs award |
Amount: $10,000 |
| Year: 2025 | Institution: Seattle Children's Research Institute | Department: Center for Integrated Brain Research |
Type of Grant:
Technology Commercialization
Ramirez: Preventing schizophrenia progression by reducing complement proteins that tag synaptic connections phase 2 indirect costs award |
Amount: $25,000 |
| Year: 2025 | Institution: Seattle University | Department: Mechanical Engineering |
Type of Grant:
Technology Commercialization
Ren: Scale-up of a single-mode electromagnetic resonant (SMER) technology to enable long-term organ preservation phase 1 award |
Amount: $109,597 |
| Year: 2025 | Institution: Seattle University | Department: |
Type of Grant:
Student Programs
Summer Innovation Fellows and mini-accelerator |
Amount: $50,000 |